Results for
"[search-keyword]"
Sponsor content
310 result(s) found, displaying 201 to 210
-
Prescription medicine registrationActive ingredients: osimertinib mesilate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SYNAGIS palivizumab (rmc) 50 mg / 0.5 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SYNAGIS palivizumab (rmc) 100 mg / 1 mL solution for injection vial.
-
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Tamoxifen
-
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Sodium zirconium cyclosilicate hydrate
-
-